.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Argus Health
Cipla
QuintilesIMS
Fuji
Farmers Insurance
US Department of Justice
Dow
Queensland Health

Generated: December 13, 2017

DrugPatentWatch Database Preview

SPECTRACEF Drug Profile

« Back to Dashboard

When do Spectracef patents expire, and when can generic versions of Spectracef launch?

Spectracef is a drug marketed by Vansen Pharma and is included in one NDA. There is one patent protecting this drug.

This drug has seventeen patent family members in fifteen countries.

The generic ingredient in SPECTRACEF is cefditoren pivoxil. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the cefditoren pivoxil profile page.

Summary for SPECTRACEF

Drug patent expirations by year for SPECTRACEF

Pharmacology for SPECTRACEF

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Vansen PharmaSPECTRACEFcefditoren pivoxilTABLET;ORAL021222-001Aug 29, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Vansen PharmaSPECTRACEFcefditoren pivoxilTABLET;ORAL021222-002Jul 21, 2008DISCNNoNo► Subscribe► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: SPECTRACEF

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Vansen PharmaSPECTRACEFcefditoren pivoxilTABLET;ORAL021222-001Aug 29, 2001► Subscribe► Subscribe
Vansen PharmaSPECTRACEFcefditoren pivoxilTABLET;ORAL021222-002Jul 21, 2008► Subscribe► Subscribe
Vansen PharmaSPECTRACEFcefditoren pivoxilTABLET;ORAL021222-002Jul 21, 2008► Subscribe► Subscribe
Vansen PharmaSPECTRACEFcefditoren pivoxilTABLET;ORAL021222-001Aug 29, 2001► Subscribe► Subscribe
Vansen PharmaSPECTRACEFcefditoren pivoxilTABLET;ORAL021222-001Aug 29, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: SPECTRACEF

Country Document Number Estimated Expiration
Mexico9802849► Subscribe
European Patent Office0862915► Subscribe
Germany69620220► Subscribe
Argentina004014► Subscribe
Spain2174109► Subscribe
Hungary9900609► Subscribe
Taiwan458778► Subscribe
Brazil9610836► Subscribe
Hungary224922► Subscribe
Portugal862915► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Farmers Insurance
McKinsey
McKesson
Citi
Novartis
Queensland Health
Covington
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot